Marksans Pharma Ltd. - India

Marksans Pharma Ltd. - India company information, Employees & Contact Information

Company Profile "The essence of our culture is built on meeting global standards in every aspect of our business." These envisioned words of Mr. Mark Saldanha, our Chairman and Managing Director, reflect the extreme passion and enthusiasm that drives the organization. Marksans Pharma, headquartered at Mumbai (India) is a global pharmaceutical company. We are actively engaged in R&D and offer CRAMS to global pharmaceutical companies. OUR FOCUS Our key focus areas lie in the OTC & prescription drugs that have wide-ranging applications across fields like Oncology, Gastroenterology, Anti-diabetic, Antibiotics, Cardiovascular, Pain Management, Gynaecology, Neuropsychiatric among others. OUR STRENGTH We have established world-class manufacturing facilities by leveraging state-of-the-art technology, incorporating best practices and adhering to stringent regulatory compliances. Our plants are approved by prestigious US FDA, UK MHRA, Australian TGA and other foreign health authorities. Our R&D capabilities include dossier development, chemical synthesis, process optimization, formulation development, analytical development and conducting stability studies. We have a team of over 50 experienced scientists specializing in formulation development and analytical development. We possess end-to-end capabilities – from Lab scale development to Pilot scale up and from commercializing the product for large scale manufacturing to marketing globally. The company has achieved global recognition within a very short span of time and has major global expansion plans for the near future.

Company Details

Employees
1.05K
Address
11 Floor, "grandeur", Opp Gundecha Symphony, Veera Desai Extension Rd,oshiwara,andheri (W),india
Phone
(22) 4001-20-00
Email
in****@****rma.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Keywords
Pharmaceutical.
HQ
Mumbai, Maharashtra
Looking for a particular Marksans Pharma Ltd. - India employee's phone or email?

Marksans Pharma Ltd. - India Questions

News

Marksans Pharma Adjusts FY26 Revenue Expectations, Maintains Strong US Order Book - scanx.trade

Marksans Pharma Adjusts FY26 Revenue Expectations, Maintains Strong US Order Book scanx.trade

Marksans Pharma share price slumps 14% to four-month low after weak Q1 results - Mint

Marksans Pharma share price slumps 14% to four-month low after weak Q1 results Mint

Stock Crash: Marksans Pharma shares tank 14% after Q1 results despite demand optimism - CNBC TV18

Stock Crash: Marksans Pharma shares tank 14% after Q1 results despite demand optimism CNBC TV18

Stocks to buy today: CCL Products, Marksans Pharma; check target, stop-loss - Business Standard

Stocks to buy today: CCL Products, Marksans Pharma; check target, stop-loss Business Standard

Marksans Pharma arm receives regulatory approval for Sennosides tablets, shares gain 6% - CNBC TV18

Marksans Pharma arm receives regulatory approval for Sennosides tablets, shares gain 6% CNBC TV18

Marksans Pharma Buyback 2022 Record Date, Price & Ratio Details - IPO Watch

Marksans Pharma Buyback 2022 Record Date, Price & Ratio Details IPO Watch

Marksans Pharma gets USFDA approval for Esomeprazole Magnesium Capsules - Business Standard

Marksans Pharma gets USFDA approval for Esomeprazole Magnesium Capsules Business Standard

Marksans Pharma Ltd (MARKSANS) Share Price - Business Today

Marksans Pharma Ltd (MARKSANS) Share Price Business Today

Marksans Pharma has rallied over 100% in 12 months and a major investor just bought stake - CNBC TV18

Marksans Pharma has rallied over 100% in 12 months and a major investor just bought stake CNBC TV18

Why did investors dump Marksans Pharma shares post Q4 results? Know here - Business Standard

Why did investors dump Marksans Pharma shares post Q4 results? Know here Business Standard

Marksans Pharma to acquire Tevapharm's bulk formulations business - Business Standard

Marksans Pharma to acquire Tevapharm's bulk formulations business Business Standard

Marksans Pharma Share Price Target 2025, 2026, 2030, 2040, 2050 - shareprice-target.com

Marksans Pharma Share Price Target 2025, 2026, 2030, 2040, 2050 shareprice-target.com

Top Marksans Pharma Ltd. - India Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant